{"database": "lobbying", "table": "lobbying_activities", "rows": [[965469, "3446857a-880a-4211-a214-8e58e0ee530d", "Q2", "AMYLIN PHARMACEUTICALS", 308536, "AMYLIN PHARMACEUTICALS", 2010, "second_quarter", "PHA", "Physician Payments Sunshine provision of Pub. L. 111-148 (Patient Protection and Affordable Care Act of 2010)\nFDA Risk Evaulation Mitigation Strategies (REMS)\nDrug Safety Communications\nDrug importation issues", "HOUSE OF REPRESENTATIVES,SENATE", null, 240000, 0, 0, "2010-07-19T16:57:15.527000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["965469"], "units": {}, "query_ms": 1.8994809943251312, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}